A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer
Keisuke Okuno, Raju Kandimalla, Marta Mendiola, Francesc Balaguer, Luís Bujanda, Carlos Fernández-Martos, Jorge Aparicio, Jaime Feliú, Masanori Tokunaga, Yusuke Kinugasa, Joan Maurel, Ajay Goel
Abstract
The present work was supported by the CA72851, CA181572, CA184792, and CA187956 grants from the National Cancer Institute, National Institute of Health; RP140784 from the Cancer Prevention Research Institute of Texas; grants from the Sammons Cancer Center and Baylor Foundation, as well as funds from the Baylor Research Institute, Dallas, TX, USA awarded to Ajay Goel. The present work was also supported by Catalan Agency for Management of University and Research Grants (AGAUR) (2014-SGR-474 and 2017-SGR-1174), Fundació la Marató de TV3 (201330.10), Instituto de Salud Carlos III (PI13/01728 and PI19/00740) and Fundacion Olga Torres (Modalitat A. 2019/2020) to Joan Maurel.